Morgan Stanley Good Rx Holdings, Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Good Rx Holdings, Inc. stock. As of the latest transaction made, Morgan Stanley holds 432,279 shares of GDRX stock, worth $1.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

432,279

Previous 730,040 40.79%

Holding current value

$1.51 Million

Previous $3.22 Million 33.15%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	SELL	$3.74 - $5.07 $1.11 Million - $1.51 Million	-297,761 Reduced 40.79%	432,279 $2.15 Million
Q1 2025 May 15, 2025	BUY	$4.15 - $5.13 $1.66 Million - $2.05 Million	399,975 Added 121.18%	730,040 $3.22 Million
Q4 2024 Feb 14, 2025	SELL	$4.15 - $7.09 $258,055 - $440,870	-62,182 Reduced 15.85%	330,065 $1.53 Million
Q3 2024 May 14, 2025	SELL	$6.69 - $9.05 $4.21 Million - $5.7 Million	-629,553 Reduced 61.61%	392,247 $2.73 Million
Q3 2024 Nov 14, 2024	SELL	$6.69 - $9.05 $4.21 Million - $5.7 Million	-629,553 Reduced 61.61%	392,247 $2.73 Million
Q2 2024 May 14, 2025	BUY	$6.5 - $8.91 $4.5 Million - $6.16 Million	691,735 Added 209.58%	1,021,800 $7.97 Million
Q2 2024 Oct 17, 2024	SELL	$6.5 - $8.91 $3.15 Million - $4.32 Million	-484,786 Reduced 32.18%	1,021,800 $7.97 Million
Q2 2024 Aug 14, 2024	SELL	$6.5 - $8.91 $3.15 Million - $4.32 Million	-484,786 Reduced 32.18%	1,021,800 $7.97 Million
Q1 2024 Oct 17, 2024	BUY	$5.37 - $8.35 $2.6 Million - $4.05 Million	484,786 Added 47.44%	1,506,586 $10.7 Million
Q1 2024 Aug 16, 2024	SELL	$5.37 - $8.35 $4.07 Million - $6.33 Million	-758,633 Reduced 33.49%	1,506,586 $10.7 Million
Q1 2024 May 15, 2024	SELL	$5.37 - $8.35 $4.07 Million - $6.33 Million	-758,633 Reduced 33.49%	1,506,586 $10.7 Million
Q4 2023 Aug 16, 2024	BUY	$4.44 - $6.7 $5.52 Million - $8.33 Million	1,243,419 Added 121.69%	2,265,219 $15.2 Million
Q4 2023 Feb 13, 2024	BUY	$4.44 - $6.7 $2.32 Million - $3.5 Million	522,560 Added 29.99%	2,265,219 $15.2 Million
Q3 2023 Nov 15, 2023	BUY	$5.23 - $9.24 $1.58 Million - $2.79 Million	302,177 Added 20.98%	1,742,659 $9.81 Million
Q2 2023 Aug 14, 2023	SELL	$4.36 - $6.2 $435,568 - $619,386	-99,901 Reduced 6.49%	1,440,482 $7.95 Million
Q1 2023 May 15, 2023	BUY	$4.71 - $6.66 $1.07 Million - $1.51 Million	227,079 Added 17.29%	1,540,383 $9.63 Million
Q4 2022 Feb 14, 2023	BUY	$4.06 - $5.71 $113,306 - $159,354	27,908 Added 2.17%	1,313,304 $6.12 Million
Q3 2022 Nov 14, 2022	SELL	$4.67 - $7.81 $82.1 Million - $137 Million	-17,572,096 Reduced 93.18%	1,285,396 $6 Million
Q2 2022 Oct 27, 2022	BUY	$5.84 - $20.02 $1.64 Million - $5.63 Million	281,300 Added 1.51%	18,857,492 $112 Million
Q2 2022 Aug 15, 2022	BUY	$5.84 - $20.02 $1.64 Million - $5.63 Million	281,300 Added 1.51%	18,857,492 $112 Million
Q1 2022 Oct 27, 2022	SELL	$13.62 - $32.45 $3.83 Million - $9.13 Million	-281,300 Reduced 1.49%	18,576,192 $359 Million
Q1 2022 May 13, 2022	BUY	$13.62 - $32.45 $77.5 Million - $185 Million	5,687,080 Added 44.12%	18,576,192 $359 Million
Q4 2021 Feb 14, 2022	BUY	$32.11 - $47.16 $263 Million - $386 Million	8,184,111 Added 173.94%	12,889,112 $421 Million
Q3 2021 Nov 15, 2021	BUY	$29.63 - $46.98 $139 Million - $221 Million	4,705,001 New	4,705,001 $193 Million

Others Institutions Holding GDRX

# of Institutions

202

Shares Held

121M

Call Options Held

715K

Put Options Held

226K

View Full List

About GoodRx Holdings, Inc.

Ticker GDRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 84,394,800
Market Cap $295M
Description
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated pri...

More about GDRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account